openPR Logo
Press release

Drug-device Combination Products Market Forecast 2035: Integrated Therapeutics and Regulatory Advancements Fuel Market Growth | Transparency Market Research, Inc

07-08-2025 03:37 PM CET | Health & Medicine

Press release from: Transparency Market Research

Drug-device Combination Products Market

Drug-device Combination Products Market

The global drug-device combination products market is poised for remarkable growth, projected to increase from US$ 252.1 Bn in 2024 to over US$ 684.6 Bn by 2035, registering a CAGR of 9.5% during the forecast period (2025-2035). This expansion is fueled by rising prevalence of chronic diseases, emergence of smart and patient-friendly drug delivery technologies, and the growing demand for self-administered therapies.

Request a sample report for key insights:

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1534

Market Drivers

Rising Prevalence of Chronic Diseases
Chronic conditions-including diabetes, cardiovascular diseases, respiratory illnesses, and cancer-drive demand for integrated therapeutic solutions. For instance, insulin pumps paired with continuous glucose monitors enable accurate dosing and real-time monitoring, enhancing glycemic control.

According to the CDC, over 37 million Americans have diabetes, highlighting a sustained need for advanced, combination treatment modalities that simplify long-term disease management.

Technological Advancements
Innovation in smart injectables, connected inhalers, wearable infusion pumps, and microneedle transdermal patches is transforming treatment delivery. Integration of IoT, AI analytics, and electronic health records (EHR) enhances real-time monitoring, personalized care, and patient adherence.

Recent FDA approvals-including ICU Medical's Plum Solo precision IV pump and Luna Diabetes' pivotal trial for its automated insulin delivery system targeting multiple daily injection (MDI) patients-illustrate the market's technological momentum.

Segmentation Insights

Product Type: Injectable Drug Delivery Devices, Infusion Pumps, Orthopedic Combination Products, Transdermal Patches, Drug Eluting Stents, Inhalers, Others (Laser-Assisted Drug Delivery, etc.)

Application: Diabetes Management, Respiratory Diseases, Eye Diseases, Autoimmune Diseases, Cancer, Pain Management, Infectious Diseases, Cardiovascular Diseases, Obesity Management, Others (Gastrointestinal Diseases, etc.)

End-user: Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Centers, Others (Nursing Homes, Research Institutes, etc.)

Explore the full report for detailed insights:

https://www.transparencymarketresearch.com/drug-device-combination.html

Regional Outlook
North America remains the largest market, driven by:

High chronic disease burden

Supportive reimbursement frameworks

Regulatory clarity from the FDA on combination product pathways

Strong presence of global leaders and advanced healthcare infrastructure

Europe benefits from strong biomedical research investment, while Asia Pacific is projected to see rapid growth, supported by rising healthcare spending, chronic disease incidence, and government-backed medical technology innovation.

Key Players Shaping the Market

Abbott

Eli Lilly and Company

Medtronic

Novo Nordisk A/S

Novartis AG

Sanofi

Boston Scientific Corporation and affiliates

BD

Merck KGaA

B. Braun SE

Stryker

Gerresheimer AG

Narang Medical Limited

Sparsha Pharma International Pvt. Ltd.

Other prominent players

These companies drive market evolution through portfolio expansion, technological partnerships, and global market entry strategies.

Recent Developments

April 2025: ICU Medical received FDA clearance for new infusion pumps, enhancing its IV Performance Platform.

October 2024: Luna Diabetes launched its pivotal trial evaluating closed-loop insulin delivery for patients on multiple daily injections.

Want to know more? Get in touch now. -https://www.transparencymarketresearch.com/contact-us.html

Future Outlook

The drug-device combination products market is set to revolutionize patient care by offering safer, smarter, and patient-centric therapeutic solutions. Growing consumer demand for personalized and home-based care, supported by technological integration, positions this market for sustained growth beyond 2035.

Explore Latest Research Reports by Transparency Market Research:

Metagenomics Market - https://www.transparencymarketresearch.com/metagenomics-market.html

Hemostatic Agents Market - https://www.transparencymarketresearch.com/hemostatic-agents-market.html

Unna Boot Market - https://www.transparencymarketresearch.com/unna-boot-market.html

Hospital Furniture Market - https://www.transparencymarketresearch.com/hospital-furniture-market.html

Sterilization Services Market - https://www.transparencymarketresearch.com/sterilization-services-market.html

Cast Saw Devices Market - https://www.transparencymarketresearch.com/cast-saw-devices-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug-device Combination Products Market Forecast 2035: Integrated Therapeutics and Regulatory Advancements Fuel Market Growth | Transparency Market Research, Inc here

News-ID: 4096348 • Views:

More Releases from Transparency Market Research

OLED Display Market to Reach US$ 304.8 Billion by 2036, Driven by Rapid Adoption in Smartphones, Wearables, and Automotive Displays | Latest Report TMR
OLED Display Market to Reach US$ 304.8 Billion by 2036, Driven by Rapid Adoption …
The global OLED display market was valued at US$ 68.1 Billion in 2025 and is projected to reach US$ 304.8 Billion by 2036, expanding at a robust compound annual growth rate (CAGR) of 14.3% from 2026 to 2036. This strong growth trajectory is fueled by the rising adoption of OLED displays in smartphones and wearable devices, increasing demand for flexible, foldable, and curved displays, and the expanding use of OLED
2-Shot Injection Molding Market to Reach US$ 19.0 Billion by 2036, Driven by Rising Demand for Multi-Material Components and Manufacturing Automation | Latest Report TMR
2-Shot Injection Molding Market to Reach US$ 19.0 Billion by 2036, Driven by Ris …
The global 2-shot injection molding market was valued at US$ 11.0 Billion in 2025 and is projected to reach US$ 19.0 Billion by 2036, expanding at a CAGR of 5.0% from 2026 to 2036. Market growth is primarily fueled by rising demand for multi-material and multi-functional components, along with increasing focus on manufacturing efficiency, cost reduction, and automation benefits across industries. Access key findings and insights from our Report in this
Neodymium Market to Reach USD 5.0 Billion by 2036 Amid EV and Wind Energy Surge
Neodymium Market to Reach USD 5.0 Billion by 2036 Amid EV and Wind Energy Surge
The global neodymium market is entering a structurally transformative decade, supported by accelerating electrification, renewable energy expansion, and strategic supply chain realignment. Valued at USD 2.1 billion in 2025, the market is projected to reach USD 5.0 billion by 2036, expanding at a steady CAGR of 8.0% from 2026 to 2036. Once primarily associated with consumer electronics, neodymium is now positioned at the core of global decarbonization strategies, electric mobility expansion,
Activated Carbon Market to Reach USD 16.4 Bn by 2036, Advancing at 11.2% CAGR on Rising Water and Air Purification Demand
Activated Carbon Market to Reach USD 16.4 Bn by 2036, Advancing at 11.2% CAGR on …
The global Activated Carbon Market was valued at approximately US$ 9.2 Bn in 2025 and is projected to reach nearly US$ 16.4 Bn by 2036, expanding at a steady CAGR of 11.2% during the forecast period. Market growth is primarily driven by increasing demand for water purification, stringent environmental regulations on air and wastewater treatment, and expanding industrial applications across pharmaceuticals, food & beverages, energy, and chemical sectors. Explore the Sample

All 5 Releases


More Releases for Diseases

Rare Kidney Diseases Market Specificity: "Rare Kidney Diseases" clearly defines …
Rare Kidney Diseases Market to is Projected to Grow at a CAGR of 16%, During the Period 2022-2030, claims InsightAce Analytic InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Rare Kidney Diseases Market By Target Indications (IgA Nephropathy, Membranous Nephropathy, Lupus Nephritis, C3 Glomerulopathy, Focal Segmental Glomerular Sclerosis, and Others), Type of Molecule (Small Molecules and Biologics (Hormone, Monoclonal Antibody, Recombinant Protein, and Others)),
Orphan Drugs Market by Disease Type (Oncological Diseases, Metabolic Diseases, H …
The global orphan drugs market size was valued at $151.00 Bn in 2019 & is projected to reach $340.84 Bn by 2027, with a CAGR of 10.5% in forecast period 2023-2032. Orphan Drugs Market Analysis and Size From 2023 to 2032, market growth is anticipated to be accelerated by the sharp increase in the prevalence of cardiovascular, diabetes, and hypertension illnesses. Similar to this, it is anticipated that rising healthcare costs
Animal Feed Enzymes Market: Rising Cases of Zoonotic Diseases and Food Borne Dis …
Combined share of a few top players in the global animal feed enzymes market is significant enough. This makes the market somewhat consolidated. Novozymes, Azelis Holdings SA, E.l. Du Pont de Nemours and Company, Lesaffre, Rossari Biotech Ltd, BASF SE, Novus International Inc., Associated British Foods plc, Bio-Cat, and Alltech Inc. are to name a few such leading players in the animal feed enzymes market. Request Sample For More Information
Sevoflurane, Isoflurane and Desflurane Market Report 2018: Segmentation by Produ …
Global Sevoflurane, Isoflurane and Desflurane market research report provides company profile for Baxter, Lunan Pharmaceutical Group, AbbVie and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the
Increasing incidence of cancer, orthopaedic diseases, and other chronic diseases …
Future Market Insights delivers key insights on the global teleradiology services market in a new publication titled “Teleradiology Services Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”. Teleradiology is the practice of interpretation and analysis of medical images by a radiologist who is not present at the site where the images are generated. This service is utilised by hospitals, emergency care centres, telemedicine companies, and other clinics. Teleradiology services enable
China In Vitro Diagnostics (IVD) Market Research Report 2016 Industry Solutions …
This report studies In Vitro Diagnostics (IVD) in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering Roche Diagnostics Abbott Laboratories Danaher Corporation Siemens Healthcare Becton Dickson and Company Ortho-Clinical Diagnostics Johnson and Johnson Thermo Fisher Scientific Bio-Rad Laboratories Sysmex Corporation bioMrieux Beckman Coulter Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into Immunoassay Clinical Chemistry Molecular Diagnostics Hematology Others Split by Application, this report focuses